Lifeline Business Profile
Rare Multi-Lineage Progenitor Cells Provide New, Viable Platform for Stem Cell Research Free from Public, Political Controversy Surrounding Use of Embryonic Stem Cells...
Rare Multi-Lineage Progenitor Cells Provide New, Viable Platform for Stem Cell Research Free from Public, Political Controversy Surrounding Use of Embryonic Stem Cells...
The facility of CBB Lifeline Biotech is Accredited by AABB International Standards for Cellular Therapy Products for Cord Blood Banking Services
Since October 2020 the clinical testing is performed by a third party accredited collaborator
LifeCord Patented Methodology
US Patent Office
